(UroToday.com) The European Multidisciplinary Congress on Urological Cancers (EMUC) 2020 virtual meeting featured a round table discussion on the impact of the COVID-19 epidemic on the management of Genitourinary (GU) cancers, including a presentation by Dr. Chris Wallis discussing the urologist’s perspective.
(UroToday.com) The European Multidisciplinary Congress on Urological Cancers (EMUC) 2020 virtual meeting featured a round table discussion on the impact of the COVID-19 epidemic on the management of Genitourinary (GU) cancers, including a presentation by Dr. Karim Fizazi discussing the medical oncologist’s perspective.
(UroToday.com) At the European Multidisciplinary Congress on Urological Cancers (EMUC) 2020 virtual meeting, Dr. Jurgen Futterer discussed the role of multiparametric MRI (mpMRI) and the role of diffusion-weighted imaging (DWI) for prostate cancer detection.
There are several promising imaging techniques on the horizon, with the potential of changing the way oncology experts treat their patients. Novel modalities in ultrasound, combined with machine learning, further evolution of PET-CT beyond PSMA, the use of nanoparticles as a contrast agent and the emergence of the VI-RADS score are all anticipated in the […]
(UroToday.com) In an oral presentation in the Refining the Treatment of Bladder Cancer session at the 12th European Multidisciplinary Congress on Urological Cancers (EMUC), Dr. Matthew Glasky presented an overview of optimal first-line approaches to the treatment of metastatic bladder cancer.
(UroToday.com) At the European Multidisciplinary Congress on Urological Cancers (EMUC) 2020 virtual meeting, Dr. Maria Ribal gave an overview of the European Association of Urology (EAU) Guideline Office Rapid Reaction Group’s (GORRG) specific recommendations during COVID-19, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which was published earlier this year in European Urology.1 With regards to […]
(UroToday.com) In an oral presentation in the New Trials Update session at the 12th European Multidisciplinary Congress on Urological Cancers (EMUC), Dr. Thomas Powles discussed the results of the DANUBE trial, Study of MEDI4736 (Durvalumab) With or Without Tremelimumab Versus Standard of Care Chemotherapy in Urothelial Cancer (DANUBE), a front-line randomized, open-label study of durvalumab monotherapy or […]
(UroToday.com) At the Highlights in Genitourinary (GU) Cancer session at the European Multidisciplinary Congress on Urological Cancers (EMUC) 2020 virtual meeting, Andre Deschamps discussed results and highlights of the Europa Uomo Patient-Reported Outcomes Study (EUPROMS), the first-ever survey in prostate cancer from patients for patients.
(UroToday.com) In an oral presentation in the New Trials Update session at the 12th European Multidisciplinary Congress on Urological Cancers (EMUC), Dr. Marc-Oliver Grimm discussed the results of the NIMBUS trial, Treatment of High-Grade Non-Muscle Invasive Urothelial Carcinoma of the Bladder by Standard Number and Dose of Intravesical BCG Instillations Versus Reduced Number of Intravesical Instillations […]
(UroToday.com) In an oral presentation in the New Trials Update session at the 12th European Multidisciplinary Congress on Urological Cancers (EMUC), Dr. Karim Fizazi presented a discussion of the results of PROfound Study, Study of Olaparib (Lynparza™) Versus Enzalutamide or Abiraterone Acetate in Men With Metastatic Castration-Resistant Prostate Cancer (PROfound), examining the role of olaparib among […]
